PEMDOTLS: Preclinical evaluation of Miltefosin derivatives optimised for the treatment of Leishmaniasis and Sleep Disease. (Q2906826): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in fr: Adding French translations) |
(Changed label, description and/or aliases in de: Adding German translations) |
||
| label / de | label / de | ||
PEMDOTLS: Präklinische Bewertung von Miltefosinderivaten, optimiert für die Behandlung von Leishmaniose und Schlafkrankheit. | |||
Revision as of 20:59, 13 December 2021
Project Q2906826 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PEMDOTLS: Preclinical evaluation of Miltefosin derivatives optimised for the treatment of Leishmaniasis and Sleep Disease. |
Project Q2906826 in Portugal |
Statements
204,000.0 Euro
0 references
240,000.0 Euro
0 references
85.0 percent
0 references
26 July 2018
0 references
25 July 2022
0 references
INSTITUTO DE BIOLOGIA MOLECULAR E CELULAR - IBMC
0 references
Q2985732 (Deleted Item)
0 references
41°8'58.02"N, 8°36'38.84"W
0 references
Porto
0 references
Identifiers
POCI-01-0145-FEDER-031013
0 references